ATLASNovartis AG (NVS) Q3 2026 earnings results
Novartis AG (NVS) reported EPS of $2.46 against an analyst estimate of $2.25: a beat of $0.21 (9.3%). The quarter ended Sep 30, 2026; the company reported on Tuesday, October 27, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Novartis AG reports
Track NVS free Add Novartis AG to a free ATLAS watchlist.
NVS Q3 2026 results at a glance
| EPS reported | $2.46 |
|---|---|
| EPS estimate | $2.25 |
| Surprise | Beat · +$0.21 (+9.3%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 27, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Novartis AG’s Q3 2026, a calendar-year company.
Novartis AG EPS surprise history: last 4 quarters
Novartis AG beat the EPS estimate in 3 of its last 4 reports, with an average surprise of +28.7%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | $2.25 | $2.46 | +9.3% | Beat | +1.5% |
| Jul 21, 2026 | $2.15 | $2.41 | +12.1% | Beat | +2.4% |
| Apr 28, 2026 | $1.65 | $1.65 | 0.0% | In line | -0.9% |
| Feb 6, 2026 | $3.18 | $6.15 | +93.4% | Beat | +2.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
NVS stock reaction to the report
NVS moved +1.98% in the first session that reflects the report (close of Oct 26, 2026 $153.81 to close of Oct 27, 2026 $156.86). Since the report: +4.99% (latest close $161.49 on Nov 2, 2026, against $153.81 before the reaction).
Next NVS earnings report
Novartis AG has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the NVS earnings calendar.
ATLAS fair value and signal for NVS
| Last price | $161.49 (+0.4%) |
|---|---|
| ATLAS fair value | $257.05 (range $197.59–$390.76) · price is 37% below it |
| Chance of a higher close in 1 month | 51% (normal range $154.02–$170.13) |
These are model outputs from the same valuation and calibrated model as the Novartis AG stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Novartis AG Q3 2026 earnings: frequently asked questions
Did Novartis AG beat earnings estimates for Q3 2026?
Novartis AG reported EPS of $2.46 against an analyst estimate of $2.25: a beat of $0.21 (9.3%).
When did Novartis AG report Q3 2026 results?
Novartis AG reported on Tuesday, October 27, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does NVS beat EPS estimates?
In its last 4 reports with a recorded result, Novartis AG beat the EPS estimate 3 times; the average surprise was +28.7%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer